Effectiveness of Oral Magnesium Supplementation in Fibromyalgia Patients Not Responding to Standard Treatment
Recruiting · NCT07585045 · Interventional (participants receive a specific treatment) · Lead sponsor: Shaikh Zayed Hospital, Lahore
View the official record on ClinicalTrials.gov →Interventions studied
Magnesium glycinateVitamins
What this trial is about
Fibromyalgia is a complex widespread pain disorder. OBJECTIVES To evaluate the effectiveness of oral magnesium supplementation in reducing symptom severity among fibromyalgia patients who have not responded to standard treatment, using validated scoring systems such as the Fibromyalgia Impact Questionnaire Revised (FIQR).
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients diagnosed with FM according to the American College of Rheumatology (ACR) 2016 criteria
- Age: 18-65 years.
- Not responding to conventional treatment (e.g., amitriptyline, duloxetine, pregabalin) for at least 8 weeks
- Patients giving informed consent for enrollment in the study.
Exclusion criteria
- 1- Patients with renal impairment 2- Pregnant or lactating women 3- Already on magnesium or other mineral supplements 4- Known cases of inflammatory arthritis or other chronic pain syndromes
Where it is running
1 location listed.
- Shaikh Zayed Hospital, Lahore - Lahore, Punjab Province, Pakistan